Jeffrey D Wetherington

Phase 3 adaptive trial design options in treatment of complicated urinary tract infection

Gang Li, Kert Viele, Linda M Mundy, 2018, Pharmaceutical statistics.

Model‐Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development

Marc Pfister, Jeffrey D Wetherington, Rajesh Krishna, 2010, Journal of clinical pharmacology.

Model‐Based Drug Development Survey Finds Pharmacometrics Impacting Decision Making in the Pharmaceutical Industry

Marc Pfister, Jeffrey D Wetherington, Rajesh Krishna, 2010, Journal of clinical pharmacology.

Multiple Test Procedures for Identifying the Maximum Safe Dose

Charles W. Dunnett, Jeffrey D Wetherington, Ajit C. Tamhane, 2001 .